FDA Authorizes New Quest Diagnostics Lab Method Designed to Increase COVID-19 Molecular Diagnostics Capacity
Technique to increase COVID-19 molecular diagnostic testing capacity and provide faster test results reporting SECAUCUS, N.J., July 29, 2020 /PRNewswire/ — Quest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process of extracting viral RNA from specimens* and will enable the company […]